Business Model Canvas: NEPD-Specific Forensic Toxicology Screening Panel
A specialized forensic diagnostic protocol for detecting N-ethylpentedrone (NEPD) by targeting its specific Phase-I and Phase-II metabolic markers in urine. The approach utilizes UHPLC-QTOF-HRMS with dual-ionization to ensure comprehensive detection of both parent compounds and glucuronidated metabolites.
The Business Model Canvas reveals a high-barrier, specialized technical offering that shifts the value from general screening to legally defensible, high-specificity forensic evidence. Success depends on integrating into the existing workflows of high-capacity diagnostic labs and government agencies through a licensing or specialized service model.
Key Partners3
Key Activities3
Key Resources3
Value Propositions3
Customer Relationships2
Channels3
Customer Segments3
Cost Structure3
Revenue Streams3
The idea has clearly identified high-value institutional customers like the FBI and WADA, making it appropriate to map the value proposition and delivery model. · Generated 2026-09-10 by cavi/gemma4-31b-it-awq-4bit-32kAI-generated